Shrewsbury, MA, United States of America

Laura Sullivan

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 6.4

ph-index = 5

Forward Citations = 37(Granted Patents)


Location History:

  • Beverly, MA (US) (2010 - 2013)
  • Shrewsbury, MA (US) (2012 - 2022)

Company Filing History:


Years Active: 2010-2022

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Laura Sullivan in Cancer Research

Introduction

Laura Sullivan, an accomplished inventor based in Shrewsbury, Massachusetts, has made significant strides in the field of cancer research. With a total of 13 patents to her name, she is recognized for her pioneering work in detecting mutant anaplastic lymphoma kinase (ALK) in lung cancer, particularly in non-small cell lung carcinoma (NSCLC). Her inventions provide valuable tools for diagnosing and potentially treating this aggressive form of cancer.

Latest Patents

Laura Sullivan's latest patents focus on compositions and methods for detecting ALK mutations in lung cancer. These innovations involve novel gene deletions and translocations on chromosome 2, resulting in the formation of fusion proteins, such as the EML4-ALK protein and TRK-Fusion Gene (TFG). Her patents encompass isolated polynucleotides and vectors encoding these mutant polypeptides, as well as probes and reagents for their detection. The significance of her work lies in the development of methods for screening compounds that inhibit the fusion proteins, ultimately aiming to inhibit the progression of cancers characterized by these mutations.

Career Highlights

Laura is affiliated with Cell Signaling Technology, Inc., where she collaborates with other talented scientists to push the boundaries of cancer research. Her extensive patent portfolio not only showcases her innovative capabilities but also highlights her contributions to the scientific community in identifying critical biomarkers for cancer treatment.

Collaborations

Throughout her career, Laura Sullivan has collaborated with notable colleagues, including Herbert Haack and Klarisa Rikova. These partnerships have enabled her to broaden her research impact and enhance the development of diagnostic tools for cancer therapies.

Conclusion

Laura Sullivan exemplifies the spirit of innovation in cancer research. Her contributions through her patents provide essential resources for detecting and targeting mutations in lung cancer, showcasing her vital role in the quest for more effective treatment options. As she continues her work, her inventions pave the way for advancements in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…